Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

Anticomplementary activity of lipid A isolated from lipopolysaccharides.

Morrison DC, Verroust P, Weigle WO.

Proc Soc Exp Biol Med. 1973 Sep;143(4):1025-30. No abstract available.

PMID:
4582770
3.

Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.

Gancevici G, Popescu C, Toporan M.

Arch Roum Pathol Exp Microbiol. 1982 Jul-Sep;41(3):239-50. No abstract available.

PMID:
6818928
4.

Complement independence of stimulation of mouse splenic B lymphocytes by mitogens.

Janossy G, Humphrey JH, Pepys MB, Greaves MF.

Nat New Biol. 1973 Sep 26;245(143):108-12. No abstract available.

PMID:
4583514
5.
6.
7.

Nonspecific resistance invoked by bacterial lipopolysaccharides against tuberculous infection.

Frigerio MJ, Kierszenbaum F, Nejamkis MR.

Int Arch Allergy Appl Immunol. 1966;30(1):75-82. No abstract available.

PMID:
5330981
8.
10.
11.

Activation of the classic and alternate complement pathways by endotoxin.

Fine DP.

J Immunol. 1974 Feb;112(2):763-9. No abstract available.

PMID:
4205207
12.

ANTICOMPLEMENTARY ACTION OF ENDOTOXIN.

MUSCHEL LH, SCHMOKER K, WEBB PM.

Proc Soc Exp Biol Med. 1964 Dec;117:639-43. No abstract available.

PMID:
14244914
13.

The effect of complement depletion on bacterial lipopolysaccharide (LPS)-induced hemodynamic and hematologic changes in the Rhesus monkey.

Ulevitch RJ, Cochrane CG, Bangs K, Herman CM, Fletcher JR, Rice CL.

Am J Pathol. 1978 Jul;92(1):227-40.

14.

LPS-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells.

Perlik V, Li Z, Goorha S, Ballou LR, Blatteis CM.

Am J Physiol Regul Integr Comp Physiol. 2005 Aug;289(2):R332-R339. Epub 2005 Mar 31.

15.
16.

Biological activity of lipopolysaccharides from oral Selenomonas.

Hofstad T, Naess V, Skaug N.

Scand J Dent Res. 1986 Dec;94(6):515-20.

PMID:
3468599
17.

Cell participation in the stimulation of immunologic response by Escherichia coli lipopolysaccharide.

Kierszenbaum F, Nota NR, Marra RB, Besuschio SC.

Int Arch Allergy Appl Immunol. 1967;32(1):91-7. No abstract available.

PMID:
4864668
18.

[Pharmacological effects on the complement system. Possibilities and limitations of anti-inflammatory therapy].

Kirschfink M.

Dtsch Med Wochenschr. 1995 Aug 4;120(31-32):1087-90. Review. German. No abstract available.

PMID:
7641591
19.

Inhibition of endotoxic lipopolysaccharide-mediated platelet aggregation by cobra venom anticomplementary factor.

Fong JS, White JG, Good RA.

Blood. 1974 Sep;44(3):399-409. No abstract available.

PMID:
4604614
20.

Supplemental Content

Support Center